Teva Pharmaceutical Industries (TEVA) ROE - Return on Equity
Current and historical Return on Equity (ROE) values for Teva Pharmaceutical Industries (TEVA) over the last 10 years.
|Medical||Medical - Generic Drugs||$21.507B||$22.385B|
|TEVA Pharmaceuticals USA, the business is to develop, manufacture, and market generic pharmaceuticals. Teva USA sells its products to chains, wholesalers, distributors, hospitals, managed care entities, and government agencies. The company markets a variety of dosage forms, including both extended and immediate release tablets and capsules, creams, ointments, solutions, and suspensions. Key therapeutic areas are the analgesic, anti-infective, cardiovascular, CNS, dermatological and anti-inflammatory categories.|